148 related articles for article (PubMed ID: 7912161)
1. GM1 ganglioside treatment partially reverses the nigrostriatal dopamine defect in the weaver mutant mouse.
Schneider JS; Smith MG; DiStefano L; Berrian J
Brain Res; 1994 Feb; 636(2):353-6. PubMed ID: 7912161
[TBL] [Abstract][Full Text] [Related]
2. GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
Goettl VM; Wemlinger TA; Duchemin AM; Neff NH; Hadjiconstantinou M
Neuroscience; 1999; 92(3):991-1000. PubMed ID: 10426539
[TBL] [Abstract][Full Text] [Related]
3. Enhanced restoration of striatal dopamine concentrations by combined GM1 ganglioside and neurotrophic factor treatments.
Schneider JS; DiStefano L
Brain Res; 1995 Mar; 674(2):260-4. PubMed ID: 7796105
[TBL] [Abstract][Full Text] [Related]
4. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
Schneider JS; Kean A; DiStefano L
J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220
[TBL] [Abstract][Full Text] [Related]
5. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
Rothblat DS; Schneider JS
Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
[TBL] [Abstract][Full Text] [Related]
6. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
Hadjiconstantinou M; Mariani AP; Neff NH
Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
[TBL] [Abstract][Full Text] [Related]
7. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.
Ueki A; Rosén L; Andbjer B; Finnman UB; Altamimi U; Janson AM; Goldstein M; Agnati LF; Fuxe K
Exp Brain Res; 1993; 93(2):259-70. PubMed ID: 8098283
[TBL] [Abstract][Full Text] [Related]
8. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism.
Schneider JS; Yuwiler A
Exp Neurol; 1989 Aug; 105(2):177-83. PubMed ID: 2568945
[TBL] [Abstract][Full Text] [Related]
9. Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
Hadjiconstantinou M; Neff NH
J Neurochem; 1988 Oct; 51(4):1190-6. PubMed ID: 3262149
[TBL] [Abstract][Full Text] [Related]
10. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
Pope-Coleman A; Tinker JP; Schneider JS
Synapse; 2000 May; 36(2):120-8. PubMed ID: 10767059
[TBL] [Abstract][Full Text] [Related]
11. Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Schneider JS
Neuropharmacology; 1992 Feb; 31(2):185-92. PubMed ID: 1553028
[TBL] [Abstract][Full Text] [Related]
12. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
[TBL] [Abstract][Full Text] [Related]
13. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice.
Date I; Felten SY; Felten DL
Neurosci Lett; 1989 Dec; 106(3):282-6. PubMed ID: 2601883
[TBL] [Abstract][Full Text] [Related]
14. Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Andersen JK; Frim DM; Isacson O; Beal MF; Breakefield XO
Brain Res; 1994 Sep; 656(1):108-14. PubMed ID: 7804823
[TBL] [Abstract][Full Text] [Related]
15. Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat.
Toffano G; Savoini GE; Moroni F; Lombardi G; Calzà L; Agnati LF
Brain Res; 1984 Apr; 296(2):233-9. PubMed ID: 6142756
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-depleting effects of MPTP and reserpine in weaver mutant mice.
Richter JA; Ghetti B; Simon JR
Mol Chem Neuropathol; 1993 Dec; 20(3):219-28. PubMed ID: 8172626
[TBL] [Abstract][Full Text] [Related]
17. The dendritic dopamine projection of the substantia nigra: phenotypic denominator of weaver gene action in hetero- and homozygosity.
Triarhou LC; Ghetti B
Brain Res; 1989 Nov; 501(2):373-81. PubMed ID: 2573407
[TBL] [Abstract][Full Text] [Related]
18. GM1 ganglioside partially rescues cultured dopaminergic neurons from MPP(+)-induced damage: dependence on initial damage and time of treatment.
Stull ND; Schneider JS; Iacovitti L
Brain Res; 1994 Mar; 640(1-2):308-15. PubMed ID: 7911728
[TBL] [Abstract][Full Text] [Related]
19. Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: effects of dose and extent of lesion.
Schneider JS; Distefano L
Neuropharmacology; 1995 May; 34(5):489-93. PubMed ID: 7566482
[TBL] [Abstract][Full Text] [Related]
20. Selective loss of monoaminergic neurons in weaver mutant mice--an immunocytochemical study.
Gupta M; Felten DL; Ghetti B
Brain Res; 1987 Feb; 402(2):379-82. PubMed ID: 2881603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
